David Needham

David Needham

orcid

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 1987 in The Journal of Physical Chemistry
Verified
Journal Article
Closed access
EEEvan. Evans
Evan. Evans
DNDavid Needham
David Needham

1 December 2001 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
DNDavid Needham
David Needham
MDMark W Dewhirst
Mark W Dewhirst

31 October 2012 in Cancer Research
Verified
Journal Article
Closed access
PDF file
AMAshley A. Manzoor
Ashley A. Manzoor
LLLars Lindner
Lars Lindner
CLChelsea D. Landon
Chelsea D. Landon
JPJi-Young Park
Ji-Young Park
ASAndrew J. Simnick
Andrew J. Simnick
MDMark W. Dewhirst
Mark W. Dewhirst
Traditionally, the goal of nanoparticle-based chemotherapy has been to decrease normal tissue toxicity by improving drug specificity to tumors. The enhanced permeability and retention effect can permit passive accumulation into tumor interstitium. However, suboptimal delivery is achieved with most nanoparticles because of heterogeneities of vascular permeability, which limits nanoparticle penetration. Furthermore, slow drug release limits bioavailability. We developed a fast drug-releasing liposome triggered by local heat that has already shown substantial antitumor efficacy and is in human trials. Here, we show that thermally sensitive liposomes (Dox-TSL) release doxorubicin inside the tumor vasculature. Real-time confocal imaging of doxorubicin delivery to murine tumors in window chambers and histologic analysis of flank tumors illustrates that intravascular drug release increases free drug in the interstitial space. This increases both the time that tumor cells are exposed to maximum drug levels and the drug penetration distance, compared with free drug or traditional pegylated liposomes. These improvements in drug bioavailability establish a new paradigm in drug delivery: rapidly triggered drug release in the tumor bloodstream. Cancer Res; 72(21); 5566–75. ©2012 AACR.

1 December 1995 in Chemical Reviews
Verified
Journal Article
Closed access
DLDanilo D. Lasic
Danilo D. Lasic
DNDavid Needham
David Needham

16 June 2007 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
MHMatthew A. Holden
Matthew A. Holden
DNDavid Needham
David Needham
HBHagan Bayley
Hagan Bayley

1 April 1993 in Biochimica et Biophysica Acta (BBA) - Biomembranes
Verified
Journal Article
Closed access
DZDoncho V. Zhelev
Doncho V. Zhelev
DNDavid Needham
David Needham